Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Prima BioMed PE Ratio 2006-2019 | IMMP

Current and historical p/e ratio for Prima BioMed (IMMP) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Prima BioMed PE ratio as of April 03, 2020 is 0.00.
  
Prima BioMed PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-04-03 0.67 inf
2019-12-31 1.79 0 0.00
2017-03-31 2.44 0 0.00
2016-12-31 2.34 0 0.00
2016-06-30 3.23 0 0.00
2015-12-31 3.80 0 0.00
2015-06-30 4.83 0 0.00
2014-12-31 2.23 0 0.00
2014-06-30 3.87 0 0.00
2013-12-31 3.67 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.026B $0.005B
Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.152B 13.85
Gilead Sciences (GILD) United States $98.468B 12.74
CSL (CSLLY) Australia $82.413B 0.00
Vertex Pharmaceuticals (VRTX) United States $61.786B 56.07
Regeneron Pharmaceuticals (REGN) United States $54.274B 22.99
Biogen (BIIB) United States $52.308B 8.93
Illumina (ILMN) United States $38.735B 40.05
Seattle Genetics (SGEN) United States $20.070B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.938B 9.25
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.036B 36.55
BioMarin Pharmaceutical (BMRN) United States $15.152B 647.77
Genmab (GMAB) Denmark $13.158B 10.21
Galapagos (GLPG) Belgium $12.305B 26.87
Alnylam Pharmaceuticals (ALNY) United States $11.965B 0.00
BioNTech SE (BNTX) Germany $11.935B 0.00
Genmab (GNMSF) Denmark $11.706B 37.65
Moderna (MRNA) United States $11.462B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.922B 51.05
QIAGEN (QGEN) Netherlands $9.172B 27.97
BeiGene (BGNE) Cayman Islands $9.117B 0.00
Exact Sciences (EXAS) United States $8.249B 0.00
Sarepta Therapeutics (SRPT) United States $7.281B 0.00
Bio-Techne Corp (TECH) United States $7.148B 48.92
ACADIA Pharmaceuticals (ACAD) United States $6.332B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.965B 15.76
Guardant Health (GH) United States $5.709B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.644B 0.00
Ascendis Pharma (ASND) Denmark $5.347B 0.00
Repligen (RGEN) United States $5.115B 93.53
Exelixis (EXEL) United States $5.045B 16.20
Acceleron Pharma (XLRN) United States $4.309B 0.00
Reata Pharmaceuticals (RETA) United States $4.282B 0.00
China Biologic Products (CBPO) China $3.976B 23.60
Adaptive Biotechnologies (ADPT) United States $3.249B 0.00
Blueprint Medicines (BPMC) United States $3.225B 0.00
Global Blood Therapeutics (GBT) United States $3.203B 0.00
Mirati Therapeutics (MRTX) United States $3.193B 0.00
Vir Biotechnology (VIR) United States $3.184B 0.00
MorphoSys AG (MOR) Germany $3.168B 0.00
Emergent Biosolutions (EBS) United States $2.998B 20.82
Zai Lab (ZLAB) China $2.995B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.837B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.796B 0.00
NeoGenomics (NEO) United States $2.538B 110.04
Amicus Therapeutics (FOLD) United States $2.400B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.396B 40.60
Bluebird Bio (BLUE) United States $2.329B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.90
Halozyme Therapeutics (HALO) United States $2.244B 0.00
Alkermes (ALKS) Ireland $2.228B 176.50
MyoKardia (MYOK) United States $2.160B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.062B 0.00
UniQure (QURE) Netherlands $2.016B 0.00
Immunomedics (IMMU) United States $2.011B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.930B 0.00
Denali Therapeutics (DNLI) United States $1.813B 0.00
Fate Therapeutics (FATE) United States $1.742B 0.00
Alector (ALEC) United States $1.720B 0.00
Amarin (AMRN) Ireland $1.707B 0.00
Principia Biopharma (PRNB) United States $1.610B 0.00
Viela Bio (VIE) United States $1.572B 0.00
Arvinas (ARVN) United States $1.553B 0.00
Eidos Therapeutics (EIDX) United States $1.534B 0.00
Zymeworks (ZYME) Canada $1.533B 0.00
Akcea Therapeutics (AKCA) United States $1.471B 31.63
Insmed (INSM) United States $1.428B 0.00
Epizyme (EPZM) United States $1.401B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.320B 0.00
Ligand Pharmaceuticals (LGND) United States $1.209B 37.55
Inovio Pharmaceuticals (INO) United States $1.128B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Zealand Pharma (ZEAL) Denmark $1.106B 0.00
Editas Medicine (EDIT) United States $1.073B 0.00
Twist Bioscience (TWST) United States $1.065B 0.00
REGENXBIO (RGNX) United States $1.031B 0.00
Coherus BioSciences (CHRS) United States $1.019B 12.13
NextCure (NXTC) United States $0.963B 0.00
Myriad Genetics (MYGN) United States $0.912B 16.10
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
NGM Biopharmaceuticals (NGM) United States $0.844B 0.00
I-Mab (IMAB) China $0.827B 0.00
Beam Therapeutics (BEAM) United States $0.827B 0.00
Novavax (NVAX) United States $0.804B 0.00
Intra-Cellular Therapies (ITCI) United States $0.798B 0.00
Revance Therapeutics (RVNC) United States $0.781B 0.00
Sangamo Therapeutics (SGMO) United States $0.752B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.722B 0.00
Adverum Biotechnologies (ADVM) United States $0.713B 0.00
Cytokineticsorporated (CYTK) United States $0.711B 0.00
Arcus Biosciences (RCUS) United States $0.664B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Bellus Health (BLU) Canada $0.662B 0.00
Retrophin (RTRX) United States $0.638B 0.00
GENFIT S.A (GNFT) France $0.620B 0.00
Cara Therapeutics (CARA) United States $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.591B 0.00
Intellia Therapeutics (NTLA) United States $0.586B 0.00
Athenex (ATNX) United States $0.580B 0.00
Codexis (CDXS) United States $0.577B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.551B 4.84
Compugen (CGEN) Israel $0.510B 0.00
AC Immune SA (ACIU) Switzerland $0.507B 12.95
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.500B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.487B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
Intrexon (PGEN) United States $0.480B 0.00
Athersys (ATHX) United States $0.473B 0.00
Frequency Therapeutics (FREQ) United States $0.471B 0.00
Castle Biosciences (CSTL) United States $0.470B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.469B 0.00
ANI Pharmaceuticals (ANIP) United States $0.463B 8.35
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.451B 0.00
Sorrento Therapeutics (SRNE) United States $0.450B 0.00
Clovis Oncology (CLVS) United States $0.448B 0.00
MeiraGTx Holdings (MGTX) United States $0.436B 0.00
Scholar Rock Holding (SRRK) United States $0.430B 0.00
Heska (HSKA) United States $0.425B 0.00
Morphic Holding (MORF) United States $0.415B 0.00
Prothena (PRTA) Ireland $0.413B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
Anika Therapeutics (ANIK) United States $0.394B 13.58
Verastem (VSTM) United States $0.391B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.388B 0.00
AnaptysBio (ANAB) United States $0.384B 0.00
UROGEN PHARMA (URGN) United States $0.384B 0.00
Agenus (AGEN) United States $0.383B 0.00
Vericel (VCEL) United States $0.382B 56.67
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
BioDelivery Sciences (BDSI) United States $0.365B 42.11
Cellectis S.A (CLLS) France $0.354B 0.00
MiMedx (MDXG) United States $0.354B 0.00
Cue Biopharma (CUE) United States $0.343B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.342B 0.00
Kala Pharmaceuticals (KALA) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.329B 9.85
Merus (MRUS) Netherlands $0.305B 0.00
Cellular Biomedicine (CBMG) United States $0.300B 0.00
WAVE Life Sciences (WVE) Singapore $0.285B 0.00
Dynavax Technologies (DVAX) United States $0.273B 0.00
Puma Biotechnology (PBYI) United States $0.273B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.267B 0.00
Syros Pharmaceuticals (SYRS) United States $0.265B 0.00
NantKwest (NK) United States $0.256B 0.00
Kamada (KMDA) Israel $0.255B 10.59
Avid Bioservices (CDMO) United States $0.245B 0.00
Precision BioSciences (DTIL) United States $0.240B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.238B 0.00
Albireo Pharma (ALBO) United States $0.235B 0.00
Gritstone Oncology (GRTS) United States $0.226B 0.00
Stemline Therapeutics (STML) United States $0.225B 0.00
Sutro Biopharma (STRO) United States $0.217B 0.00
Seres Therapeutics (MCRB) United States $0.216B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.216B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.210B 0.00
Geron (GERN) United States $0.210B 0.00
Aduro Biotech (ADRO) United States $0.205B 0.00
MannKind (MNKD) United States $0.200B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Alcobra (ARCT) United States $0.197B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.188B 1.69
XOMA (XOMA) United States $0.181B 0.00
VBI Vaccines (VBIV) United States $0.180B 0.00
Starpharma Holdings (SPHRY) Australia $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.175B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
Protagonist Therapeutics (PTGX) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.158B 0.00
Prometic Life Sciences (LMNL) Canada $0.156B 0.00
IVERIC Bio (ISEE) United States $0.152B 0.00
OSMOTICA PHARM (OSMT) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
Fortress Biotech (FBIO) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Aytu Bioscience (AYTU) United States $0.147B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
AIT Therapeutics (XAIR) United States $0.136B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Kindred Biosciences (KIN) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Theratechnologies (THTX) Canada $0.129B 0.00
Cerecor (CERC) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.123B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Exicure (XCUR) United States $0.119B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.117B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.115B 0.00
VTv Therapeutics (VTVT) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.095B 0.00
Strongbridge Biopharma (SBBP) United States $0.094B 0.00
TELA Bio (TELA) United States $0.091B 0.00
Aptinyx (APTX) United States $0.091B 0.00
OvaScience (MLND) United States $0.089B 0.00
PHASEBIO PHARMA (PHAS) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Five Prime Therapeutics (FPRX) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.078B 0.00
Orgenesis (ORGS) United States $0.073B 4.27
Clearside Biomedical (CLSD) United States $0.071B 0.00
Cyclerion Therapeutics (CYCN) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.063B 0.00
Arbutus Biopharma (ABUS) Canada $0.063B 0.00
Eton Pharmaceuticals (ETON) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
SESEN BIO, INC (SESN) United States $0.057B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Synlogic (SYBX) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Trevena (TRVN) United States $0.046B 0.00
Catalyst Biosciences (CBIO) United States $0.045B 0.00
Stealth BioTherapeutics (MITO) United States $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Soligenix (SNGX) United States $0.038B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Lumos Pharma (LUMO) United States $0.032B 0.00
CollPlant Holdings (CLGN) Israel $0.032B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Evogene (EVGN) Israel $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
BioCardia (BCDA) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Aptevo Therapeutics (APVO) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00